GABAPENTIN
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69097-943 -
Package NDC
69097-943-07 -
Package NDC
69097-943-12 -
Application number
ANDA090705 -
SPL ID
fdeea2da-e306-45d8-a27a-e8be090319ea -
SPL set ID
9e4eca9c-6a2c-4ede-a252-1a27094bf594 -
UNII
6CW7F3G59X -
RxCUI
310430 -
RxCUI
310431 -
RxCUI
310432
What the source publishes
- Labeler
- Cipla USA Inc.
- Active ingredients
- GABAPENTIN
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "GABAPENTIN",
"splId": "fdeea2da-e306-45d8-a27a-e8be090319ea",
"labels": [
{
"setId": "9e4eca9c-6a2c-4ede-a252-1a27094bf594",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9e4eca9c-6a2c-4ede-a252-1a27094bf594",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9e4eca9c-6a2c-4ede-a252-1a27094bf594"
}
],
"routes": [
"ORAL"
],
"labeler": "Cipla USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 CAPSULE in 1 BOTTLE (69097-943-07)",
"package_ndc": "69097-943-07",
"identifierStatus": "well-formed",
"marketing_start_date": "20171205"
},
{
"sample": false,
"description": "500 CAPSULE in 1 BOTTLE (69097-943-12)",
"package_ndc": "69097-943-12",
"identifierStatus": "well-formed",
"marketing_start_date": "20171205"
}
],
"productId": "69097-943_fdeea2da-e306-45d8-a27a-e8be090319ea",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "69097-943",
"deaSchedule": null,
"genericName": "GABAPENTIN",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "GABAPENTIN",
"strength": "300 mg/1"
}
],
"applicationNumber": "ANDA090705",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20171205",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008486"
],
"upc": [
"0369097815073",
"0369097813079",
"0369097943073",
"0369097814076"
],
"unii": [
"6CW7F3G59X"
],
"rxcui": [
"310430",
"310431",
"310432"
],
"spl_set_id": [
"9e4eca9c-6a2c-4ede-a252-1a27094bf594"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"manufacturer_name": [
"Cipla USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69097-943_fdeea2da-e306-45d8-a27a-e8be090319ea"